https://www.avient.com/sites/default/files/2020-09/stan-tone-hcc-product-bulletin-1.pdf
%
Specific
Gravity
Color
Index
Heat
Stability Lightfastness
WHITE
HCC-12144 Titanium Dioxide,
Anatase 61 1.89 PW-6 1 I/O C
HCC-12145 Titanium Dioxide,
Rutile 70 2.09 PW-6 1 I/O
YELLOW
HCC-12148 (a) Diarylide AAOT GS 35 1.09 PY-14 3 I
HCC-12516 (a) Diarylide AAMX RS 30 1.07 PY-13 3 I
HCC-12149 (a) Diarylide HR RS 22 1.04 PY-83 2 I/O (Mass)
HCC-12194 Iron Oxide 70 2.08 PY-42 2 C I/O
HCC-12503 Benzimidazolone GS 30 1.09 PY-151 2 I/O (Mass)
HCC-5253 (b) Isoindolinone RS 30 1.12 PY-110 1 I/O
ORANGE
HCC-17394 Benzimidazolone RS 20 1.05 PO-36 2 I/O
HCC-17747 Azo YS 30 1.11 PO-64 2 I/O
HCC-33428 Dianisidine RS 29 1.06 PO-16 3 I/O (Mass)
RED
HCC-12156 (a) Red 2B, Ca Salt BS 30 1.12 PR-48:2 2 I/O (Mass)
HCC-12160 (a) Red 2B, Ca Salt YS 33 1.12 PR-48:1 2 I/O (Mass)
HCC-12158 (a) Pyrazolone YS 25 1.05 PR-38 2 C I/O (Mass)
HCC-12159 Pigment Scarlet BS 38 1.21 PR-60:1 2 I/O (Mass)
HCC-12196 Iron Oxide, Dark VBS 65 2.09 PR-101 1 I/O
HCC-12197 Iron Oxide, Light BS 70 2.24 PR-101 1 I/O
HCC-18653 Iron Oxide, Light VYS 70 2.23 PR-101 1 I/O
HCC-11796 (a) Specialty Naphthol
BS 32 1.06 PR-170 2 I/O (Mass) C
HCC-12742 (a) Specialty Naphthol
YS 30 1.07 PR-170 2 I/O (Mass) C
HCC-2160 (b) Quinacridone BS 26 1.08 PV-19 2 I/O
HCC-12309 Quinacridone YS 25 1.07 PV-19 2 I/O
HCC-7707 Perylene Scarlet YS 25 1.04 PR-149 2 I/O
HCC-15738 Diketo-Pyrrolo-
Pyrrol YS 30 1.1 PR-254 1 I/O
BLUE
HCC-12164 Phthalocyanine GS 27 1.08 PB-15:3 1 I/O
HCC-12166 Phthalocyanine RS 18 1.05 PB-15 1 I/O
HCC-12168 Phthalocyanine
RS-NC 32 1.11 PB-15:1 1 I/O
HCC-12929 (c) Ultramarine 53 1.4 PB-29 1 I/O
Stan-Tone
Code
Pigment
Type
Approx. %
Approx. %
Solids
Color
Index
pH
Typical Lightfastness
GREEN
HCC-12172 Phthalocyanine BS 17 1.07 PG-7 1 I/O
HCC-12173 Phthalo Brominated
VYS 25 1.16 PG-36 1 I/O
HCC-10562 Phthalocyanine YS 30 1.15 PG-7 1 I/O
HCC-12176 Chromium Oxide 80 2.8 PG-17 1 I/O
VIOLET/MAGENTA
HCC-17680 (c) Ultramarine Violet 50 1.46 PV-15 1 I/O
HCC-2170 (b) Quinacridone Violet 30 1.09 PV-19 2 I/O
HCC-14562 Quinacridone
Magenta 25 1.06 PR-122 2 I/O
HCC-26775 Benzimidazolone 20 1.03 PV-32 2 I/O
HCC-33159 (a) Carbazole Violet 12 1.03 PV-23 2 I/O
BROWN/TAN
HCC-1286 (b) Iron Oxide, Tan HR 60 1.85 PBr-11 1 I/O
HCC-12201 Iron Oxide, Light 71 2.21 PBr-6 2 C I/O
HCC-12202 Iron Oxide, Dark 67.5 2.06 PBr-6 2 C I/O
BLACK
HCC-12203 Furnace-High Jet 18 1.06 PBk-7 1 I/O
HCC-12204 Furnace-High Jet 6 1 PBk-7 1 I/O
HCC-12205 Furnace-Low Jet 34 1.15 PBk-7 1 I/O
HCC-12206 Furnace-Medium Jet 20 1.07 PBk-7 1 I/O
HCC-18654 Furnace-Ultra High
Jet 15 1.04 PBk-7 1 I/O
HCC-14674 Iron Oxide 59 1.82 PBk-11 2 C I/O
ALUMINUM
HCC-12177 Aluminum 50 1.43 PM-1 2 I/O
HCC
RS = Red Shade
YS = Yellow Shade
VYS = Very Yellow Shade
BS = Blue Shade
VBS = Very Blue Shade
GS = Green Shade
NC = Non-Crystallizing
HR = Heat-Resistant
(a) = Potential Bleed / Migration
(b) = ESO plasticizer (Epoxidized Soybean Oil)
(c) = Pigment may fade in acidic environment
LIGHTFASTNESS
I = Indoor Only
I/O = Indoor or Outdoor
Mass = Outdoor Masstone Application Only
C = Some Caution Advised
HEAT STABILITY
1 = Above 400°F
2 = 350°F–400°F
3 = Below 350°F
C = Some Caution Advised
www.avient.com
Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/AVNT February IR Presentation_w_Non-GAAP Recs.pdf
Pro Forma Financial Information
The Company acquired Avient Protective Materials (“Dyneema”) on September 1, 2022 (the “Acquisition Date”) and sold the Distribution segment on November 1, 2022.
Continue fostering our Great
Place to Work® culture
Strategic Objectives
Long Term
Growth
Rates
Growth Drivers
$340
$455
$790
$1,135
$51 $84
$212
$645
$108 $113
$231 $230
$265
$358
$726 $725
8-12% 8-10% 8-10% 5%
Sustainable Solutions Composites Healthcare Asia/Emerging Regions
Profitable Growth Great Place to Work
5.4%
10.9%
16.0%
2006 2014 2023
EBITDA Margins
$0.14
$1.93
$2.36
2006 2014 2023
TOP-TIER SUSTAINABILITY PERFORMANCE
AND RECOGNITION
Industry Sustainability Standards
ESG Ratings Performance
1
4
87th
94th
percentile
5
Avient CDP Score:
A-
FE BRUARY 14 , 2024
W E BCAS T
P RE S E N TAT I O N
DR.
ASHISH KHANDPUR
PRESIDENT & CEO
7
8
PORTFOLIO TRANSFORMATION
8
46%
66%
87%
100%
0%
20%
40%
60%
80%
100%
2005 2010 2015 2020 2023
%
o
f A
dj
us
te
d
EB
IT
D
A
Commodity JVs Distribution Performance Products & Solutions Specialty Businesses
Adjusted EBITDA from Specialty Applications
SUSTAINABILITY AS A GROWTH DRIVER
9
LONG-TERM REVENUE GROWTH DRIVERS
Sustainable
Solutions
Composites, Healthcare,
Asia / LATAM
Overlap
Other
60%+
Key Growth
Drivers
Total Company Revenue
Growth Drivers Long-Term
Growth Rate
Sustainable Solutions 8–12%
Composites 8–10%
Healthcare 8–10%
Asia / LATAM 5%
Other 0–2%
Avient 6%
END MARKET OBSERVATIONS
(% OF COMPANY SALES)
ENERGY
DEFENSE
TELECOMMUNICATIONS
HEALTHCARE
10
TRANSPORTATION
INDUSTRIAL
BUILDING &
CONSTRUCTION 9%
CONSUMER
PACKAGING
23%
11
REGIONAL OBSERVATIONS
(% OF COMPANY SALES)
11
Q 4 2023 RE S U LT S
Q4 2023 PERFORMANCE VS.